Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular etanercept for inflammatory arthritis
NL-OMON23874Phase 3Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in autoimmune arthritis, rheumatoid arthritis (RA), ankylosing spondylitis (AS) and 1 more comparing Intra-articular etanercept with Matching placebo (2 arms). Primary endpoints: Composite change index in clinical symptoms, VAS subject assessment of pain and 5 more. Planned start Dec 2007; status: not yet recruiting.
02
Drugs
etanercept
03
Conditions
autoimmune arthritisrheumatoid arthritis (RA)ankylosing spondylitis (AS)psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NL-OMON23874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23874.